Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and Herbicides
US-2017223964-A1 · Aug 10, 2017 · US
US10556844B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10556844-B2 |
| Application number | US-201615548561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 5, 2016 |
| Priority date | Feb 6, 2015 |
| Publication date | Feb 11, 2020 |
| Grant date | Feb 11, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Pyrazole derivatives as nitrification inhibitors are described herein.
Opening claim text (preview).
The invention claimed is: 1. A method for reducing nitrification, the method comprising: applying a composition comprising a compound of Formula I, or a stereoisomer, a salt, a tautomer, or N-oxide thereof, to a locus where nitrification occurs, wherein R 1 is C 4 -C 6 -alkynyl, propargyl, or C 3 -C 6 -allenyl, wherein the C-atoms of these groups optionally carry 1, 2, or 3 identical or different substituents selected from the group consisting of halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , O(C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , S(O) m R a , and S(O) m NR c R d ; R 2 , R 3 and R 4 are independently selected from the group consisting of H, halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , S(O) m R a , S(O) m NR c R d ; C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, wherein the C-atoms of these groups optionally carry 1, 2, or 3 identical or different substituents selected from the group consisting of halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , S(O) m R a , and S(O) m NR c R d ; C 6 -C 10 -aryl, and C 5 -C 10 -hetaryl, wherein the aromatic moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, OR a , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, and C 2 -C 4 -alkynyl; or R 3 and R 4 together form a bridge, which forms together with the atoms to which R 3 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic or heterocyclic ring, wherein the heterocyclic ring may carry 1, 2, or 3 heteroatoms being selected from O, S, and N, of which at least one of S and N may optionally be oxidized, and wherein the carbocyclic or heterocyclic ring optionally carries carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , O(C═O)NR c R d , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl, wherein the C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, C 1 -C 4 -alkyl, and C 1 -C 4 -haloalkyl; or R 2 and R 4 together form a bridge, which forms together with the atoms to which R 2 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic or heterocyclic ring, wherein the heterocyclic ring may carry 1, 2, or 3 heteroatoms being selected from O, S, and N, of which at least one of S and N may optionally be oxidized, and wherein the carbocyclic or heterocyclic ring optionally carries carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , NO 2 , NR c R d , NR b (C═O)R a , C(═O)R a , C(═O)OR a , C(═O)NR c R d , O(C═O)NR c R d , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl, wherein the C 6 -C 10 -aryl, C 5 -C 10 -hetaryl, C 5 -C 10 -carbocyclyl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, C 1 -C 4 -alkyl, and C 1 -C 4 -haloalkyl; R a is selected from the group consisting of H, C 1 -C 8 -haloalkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl; C 5 -C 10 -hetaryl and C 6 -C 10 -aryl, wherein the C 5 -C 10 -hetaryl or C 6 -C 10 -aryl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, OH, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl, C 5 -C 6 -hetaryl and C 6 -aryl, wherein said C 5 -C 6 -hetaryl and C 6 -aryl moieties optionally carry 1, 2, 3, 4, or 5 substituents selected from the group consisting of halogen, CN, OH, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, and C 2 -C 4 -alkynyl; R b is selected from the group consisting of H, C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 4 -alkenyl, C 2 -C 8 -alkynyl, and C 6 -C 10 -aryl; R o and R d are independently selected from the group consisting of H, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 8 -cycloalkyl, C 6 -C 10 -aryl, and C 5 -C 10 -hetaryl; or R c and R d together with the N-atom to which they are bonded form a 5- to 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S, and N as a ring member atom, of which at least one S and N may optionally be oxidized, and wherein the heterocyclic ring optionally carries 1, 2, 3, 4, or 5 substituents, which are independently selected from the group consisting of halogen, CN, OH, NO 2 , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, and C 1 -C 4 -haloalkoxy; and m is 0, 1, or 2. 2. The method according to claim 1 , wherein: R 1 is a terminal C 4 -alkynyl group or propargyl. 3. The method according to claim 1 , wherein: R 1 is a terminal C 3 -C 4 -allenyl group. 4. The method according to claim 1 , wherein: R 2 , R 3 and R 4 are independently selected from the group consisting of H, halogen, CN, OR a , C(═O)R a , C(═O)OR a , C(═O)NR c R d ; C 1 -C 8 -alkyl, wherein the C-atoms optionally carry 1, 2, 3 identical or different substituents selected from the group consisting of halogen, CN, OR a ; C 6 -C 10 -aryl, and C 5 -C 10 -hetaryl, wherein the aromatic moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, OR a , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, and C 2 -C 4 -alkynyl; or R 3 and R 4 together form a bridge, which forms together with the atoms to which R 3 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic ring, wherein the carbocyclic ring optionally carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , O(C═O)NR c R d , C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl, wherein the C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, and C 1 -C 4 -haloalkyl; or R 2 and R 4 together form a bridge, which forms together with the atoms to which R 2 and R 4 are bonded an annulated partly or fully unsaturated, or aromatic 5 to 10-membered carbocyclic ring, wherein the carbocyclic ring optionally carries 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, OR a , O(C═O)NR c R d , C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl, wherein the C 5 -C 10 -hetaryl, and C 5 -C 10 -heterocyclyl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of ═O, halogen, CN, and C 1 -C 4 -haloalkyl; R a is selected from the group consisting of H, C 1 -C 8 -alkyl, C 1 -C 8 -haloalkyl, C 2 -C 8 -alkynyl; C 5 -C 10 -hetaryl or C 6 -C 10 -aryl, wherein the C 5 -C 10 -hetaryl or C 6 -C 10 -aryl moieties optionally carry 1, 2, 3, 4, or 5 identical or different substituents selected from the group consisting of halogen, CN, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkynyl, C 5 -C 6 -hetaryl and C 6 -aryl, wherein said C 5 -C 6 -hetaryl and C 6 -aryl moieties optionally carry 1, 2, 3, 4, or 5 subs
Benzopyrazoles; Hydrogenated benzopyrazoles · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
directly linked by a ring-member-to-ring-member bond · CPC title
1,2-Diazoles; Hydrogenated 1,2-diazoles · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.